These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 32197754)
1. Pharmacist intervention in colorectal cancer screening initiative. Holle LM; Levine J; Buckley T; White CM; White C; Hadfield MJ J Am Pharm Assoc (2003); 2020; 60(4):e109-e116. PubMed ID: 32197754 [TBL] [Abstract][Full Text] [Related]
2. Evaluating the appropriateness of a community pharmacy model for a colorectal cancer screening program in Catalonia (Spain). Santolaya M; Aldea M; Grau J; Estrada M; Barau M; Buron A; Francesc M; Castell A; Rodriguez C; Gascón P; Rius P; Guayta-Escolies R; J Oncol Pharm Pract; 2017 Jan; 23(1):26-32. PubMed ID: 26563130 [TBL] [Abstract][Full Text] [Related]
3. Patient perspectives on a proposed pharmacy-based colorectal cancer screening program. Ferrari RM; Atkins DL; Wangen M; Rohweder CL; Waters AR; Correa S; Richmond J; van Rensburg D; Ittes A; Odebunmi O; Issaka RB; Ceballos R; Shah PD; Wheeler SB; Brenner AT Transl Behav Med; 2023 Dec; 13(12):909-918. PubMed ID: 37756664 [TBL] [Abstract][Full Text] [Related]
4. Role of community pharmacies in a population-based colorectal cancer screening program. Vives N; Milà N; Binefa G; Travier N; Farre A; Vidal C; Sattari M; Bagaria G; Garcia M Prev Med; 2021 Apr; 145():106420. PubMed ID: 33422578 [TBL] [Abstract][Full Text] [Related]
5. Colorectal cancer screening knowledge among community pharmacists: A national survey. Odebunmi OO; Wangen M; Waters AR; Ferrari RM; Marciniak MW; Rohweder C; Wheeler SB; Brenner AT; Shah PD J Am Pharm Assoc (2003); 2024 May; ():102130. PubMed ID: 38796158 [TBL] [Abstract][Full Text] [Related]
6. Expanding access to HIV testing through Canadian community pharmacies: findings from the APPROACH study. Kelly DV; Kielly J; Hughes C; Gahagan J; Asghari S; Hancock S; Burt K; Smyczek P; Charlton C; Nguyen H BMC Public Health; 2020 May; 20(1):639. PubMed ID: 32380978 [TBL] [Abstract][Full Text] [Related]
7. Primary care provider perspectives on the role of community pharmacy in colorectal cancer screening: a qualitative study. Brenner AT; Rohweder CL; Wangen M; Atkins DL; Ceballos RM; Correa S; Ferrari RM; Issaka RB; Ittes A; Odebunmi OO; Reuland DS; Waters AR; Wheeler SB; Shah PD BMC Health Serv Res; 2023 Aug; 23(1):892. PubMed ID: 37612656 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of community pharmacy service mix: evidence from the 2004 National Pharmacist Workforce Study. Doucette WR; Kreling DH; Schommer JC; Gaither CA; Mott DA; Pedersen CA J Am Pharm Assoc (2003); 2006; 46(3):348-55. PubMed ID: 16739756 [TBL] [Abstract][Full Text] [Related]
9. Involving the public and other stakeholders in development and evaluation of a community pharmacy alcohol screening and brief advice service. Krska J; Mackridge AJ Public Health; 2014 Apr; 128(4):309-16. PubMed ID: 24713598 [TBL] [Abstract][Full Text] [Related]
10. Characteristics of unmet demand for pharmacists: a survey of rural community pharmacies in Wisconsin. Gadkari AS; Mott DA; Kreling DH; Bonnarens JK J Am Pharm Assoc (2003); 2008; 48(5):598-609. PubMed ID: 18826899 [TBL] [Abstract][Full Text] [Related]
11. Pharmacist-initiated hepatitis C virus screening in a community pharmacy to increase awareness and link to care at the medical center. Isho NY; Kachlic MD; Marcelo JC; Martin MT J Am Pharm Assoc (2003); 2017; 57(3S):S259-S264. PubMed ID: 28506379 [TBL] [Abstract][Full Text] [Related]
12. Evaluating the impact of influenza and streptococcus point-of-care testing and collaborative practice prescribing in a community pharmacy setting. Kirby J; Mousa N J Am Pharm Assoc (2003); 2020; 60(3S):S70-S75. PubMed ID: 32253085 [TBL] [Abstract][Full Text] [Related]
13. Perspectives of athletes and pharmacists on pharmacist-provided sports supplement counseling: An exploratory study. Howard MS; DiDonato KL; Janovick DL; Schroeder MN; Powers MF; Azzi AG; Lengel AJ J Am Pharm Assoc (2003); 2018; 58(4S):S30-S36.e2. PubMed ID: 30006185 [TBL] [Abstract][Full Text] [Related]
14. Implementation of technician-driven medication therapy management program in community pharmacies. Burnside TPT; Scott NJ; Smith MG J Am Pharm Assoc (2003); 2019; 59(4S):S156-S160.e2. PubMed ID: 31326039 [TBL] [Abstract][Full Text] [Related]
15. Stroke patients' support: evaluation of knowledge, practices and training needs of French community pharmacists. Khettar S; Viprey M; Haesebaert J; Jacquin-Courtois S; Luauté J; Mechtouff L; Derex L; Rode G; Dussart C; Janoly-Dumenil A Int J Clin Pharm; 2021 Aug; 43(4):980-989. PubMed ID: 33387187 [TBL] [Abstract][Full Text] [Related]
16. Pharmacist-reported practice change as a result of a statewide community pharmacy accreditation program. Frey M; Trapskin K; Margolis A; Sutter S; Cory P; Decker C J Am Pharm Assoc (2003); 2019; 59(3):403-409. PubMed ID: 30940517 [TBL] [Abstract][Full Text] [Related]
17. Pharmacists perceptions of providing colorectal cancer screening in community-based practice. Urbanek M; Hanna C; Eckmann L; Carr M; Schadler A; Kebodeaux C J Am Pharm Assoc (2003); 2024; 64(4S):102111. PubMed ID: 38723852 [TBL] [Abstract][Full Text] [Related]
18. Patient attitudes regarding pharmacist-administered memory screening in community pharmacies. Breslow RM J Am Pharm Assoc (2003); 2013; 53(6):648-51. PubMed ID: 24185433 [TBL] [Abstract][Full Text] [Related]
19. Developing and testing evidence-based weight management in Australian pharmacies: A Healthier Life Program. Um IS; Krass I; Armour C; Gill T; Chaar BB Int J Clin Pharm; 2015 Oct; 37(5):822-33. PubMed ID: 25920908 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of community pharmacy-based services for type-2 diabetes in an Indonesian setting: pharmacist survey. Wibowo Y; Parsons R; Sunderland B; Hughes J Int J Clin Pharm; 2015 Oct; 37(5):873-82. PubMed ID: 25986291 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]